Shanghai Pharmaceuticals Holding Co., Ltd (ADR)
General ticker "SHPMY" information:
- Sector: Health Care
- Industry: Medical - Distribution
- Capitalization: $5.7B (TTM average)
Shanghai Pharmaceuticals Holding Co., Ltd (ADR) follows the US Stock Market performance with the rate: 31.4%.
Estimated limits based on current volatility of 0.0%: low 7.60$, high 7.60$
Factors to consider:
- Company pays dividends (irregularly): last record date 2025-12-31, amount 0.06$ (Y0.79%)
- Earnings for 6 months up through Q2 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [7.60$, 11.37$]
- 2025-12-31 to 2026-12-31 estimated range: [8.73$, 12.84$]
Financial Metrics affecting the SHPMY estimates:
- Positive: with PPE of 9.7 at the end of fiscal year the price was low
- Positive: Operating cash flow per share per price, % of 13.01 > 12.96
- Positive: -4.75 < Operating profit margin, % of 2.96
- Negative: Industry earnings per price (median), % of 1.10 <= 4.49
- Positive: Investing cash flow per share per price, % of 0.93 > -0.63
- Negative: 0 < Inventory ratio change, % of 0.06
- Positive: -9.07 < Industry operating profit margin (median), % of 0.76
Short-term SHPMY quotes
Long-term SHPMY plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | CNY260,295.09MM | CNY275,250.93MM | CNY283,579.60MM |
| Operating Expenses | CNY252,627.85MM | CNY267,110.22MM | CNY273,637.52MM |
| Operating Income | CNY7,667.23MM | CNY8,140.71MM | CNY9,942.09MM |
| Non-Operating Income | CNY-612.94MM | CNY-120.71MM | CNY-122.28MM |
| Interest Expense | CNY1,663.55MM | CNY1,625.90MM | CNY1,685.89MM |
| R&D Expense | CNY2,204.03MM | CNY2,394.43MM | CNY2,340.01MM |
| Income(Loss) | CNY7,054.30MM | CNY8,020.01MM | CNY9,819.81MM |
| Taxes | CNY1,887.73MM | CNY2,149.99MM | CNY2,846.09MM |
| Profit(Loss)* | CNY3,768.00MM | CNY4,552.53MM | CNY5,724.56MM |
| Stockholders Equity | CNY68,524.14MM | CNY71,675.62MM | CNY75,891.33MM |
| Inventory | CNY36,623.39MM | CNY38,943.67MM | CNY45,358.95MM |
| Assets | CNY211,972.53MM | CNY221,209.43MM | CNY233,148.77MM |
| Operating Cash Flow | CNY5,231.52MM | CNY5,827.26MM | CNY6,154.20MM |
| Capital expenditure | CNY2,970.61MM | CNY2,400.88MM | CNY2,325.88MM |
| Investing Cash Flow | CNY-2,491.87MM | CNY415.98MM | CNY-3,982.23MM |
| Financing Cash Flow | CNY231.85MM | CNY-1,863.93MM | CNY-5,651.77MM |
| Earnings Per Share** | CNY5.10 | CNY6.15 | CNY7.70 |
| Ordinary share to ADR | 1.00x | 1.00x | 1.00x |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.